OROFAR

This brand name is authorized in Lithuania, Poland, Romania

Active ingredients

The drug OROFAR contains a combination of these active pharmaceutical ingredients (APIs):

1 Benzoxonium UNII 12IMO9R11X - BENZOXONIUM CHLORIDE

Benzoxonium is an antiseptic/disinfectant. Read about Benzoxonium

2 Lidocaine UNII 98PI200987 - LIDOCAINE

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane. Read about Lidocaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R02AA20	Various	R Respiratory system → R02 Throat preparations → R02A Throat preparations → R02AA Antiseptics
Discover more medicines within R02AA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1020680, 1026326, 1029924
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100107597, 100113221
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67096001, W67097001